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ABSTRACT 
 
Notwithstanding the proposed use of Cost-Utility Analysis (CUA) to inform health care 
priority setting in New Zealand, to date there has been no research into New Zealanders’ 
valuations of health-related quality of life. This paper reports the results of a study of the 
health state preferences of adult New Zealanders generated from a postal survey to which 
1360 people responded (a 50% response rate). The survey employed a self-completed 
questionnaire in which a selection of health states were described using the EQ-5D health 
state classification system and respondents’ valuations were sought using a visual analogue 
scale (VAS). Close attention is paid to the quality of the data, in particular to the ‘logical 
inconsistencies’ in respondents’ valuations. Regression analysis is used to interpolate values 
over the 245 possible EQ-5D states. Two tariffs of health state preferences, arising from 
contrasting treatments of the logical inconsistencies, are reported. 
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1. INTRODUCTION 
 
Economic analysis is increasingly used to inform decisions about the allocation of resources 
between alternative health care programmes. In New Zealand particular interest has been shown 
by key public sector agencies in Cost-Utility Analysis (CUA) to assist in prioritising health 
spending (HFA 1998, Pharmac 1998) and this has attracted both considerable debate and support 
(Devlin et al. 1999). 
 
One of the concerns raised is the lack of New Zealand evidence on the valuation of quality of 
life (Ashton et al. 1999). Notwithstanding the policy relevance of such research, none has been 
undertaken in New Zealand to date; economic analyses currently rely on health state valuations 
from other countries for the estimation of Quality-Adjusted Life Years (QALYs). Yet there is the 
possibility that New Zealanders’ health state preferences differ from those of people of other 
countries. This paper represents a first attempt to explore and report on the health state 
preferences of New Zealanders. Specifically, our aim is to produce a ‘tariff’ of health state 
preferences which will better inform the use of CUA in New Zealand.  
 
A consensus emerging in the literature (Weinstein et al. 1996, Dolan 1999) is that such a tariff is 
most appropriately based on the values assigned to a set of hypothetical states by the general 
public (in their dual roles as tax-payers and potential patients) behind ‘a veil of ignorance’. This 
consensus has been accompanied by the development of standardised methodologies for eliciting 
health state preferences. There are two aspects to this work. The first is the development of 
generic health state classification systems, which describe ‘health’ in a general (non-disease-
specific) manner, defining it on a number of ‘dimensions’ such as problems with pain, mobility 
and so on. Second is the testing of alternative methods of eliciting preferences for health states 
defined on such systems, including visual analogue scales, standard gamble and time trade-off 
techniques. 
 
The health state classification system and preference-elicitation method used in the present 
research is outlined in the following section, followed by a description of the characteristics of 
the data that were generated from it. Close attention is paid in section 3 to the ‘logical 
inconsistencies’ discovered in respondents’ valuations. In section 4 the model and regression 
techniques used to analyse the data are described, and in section 5 the regression results are 
presented. Section 6 reports the two tariffs of health state preferences that arose from contrasting 
treatments of the logical inconsistencies in the data. In closing, we draw attention to a number of 
remaining methodological issues. 
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2. THE  DATA 
 
2.1  The Survey Instrument 
 
This study employs the health state classification system known as the EQ-5D, developed by the 
EuroQol Group and considered to be one of the systems of choice internationally (Weinstein et 
al. 1996). Alternative leading systems such as the Health Utilities Index (HUI) have more 
dimensions and levels with which to represent any given health state, resulting in greater 
sensitivity but also greater difficulty in eliciting population preferences. The EQ-5D and 
associated preference elicitation instruments has the additional appeal of being available in the 
public domain. Given the possibility that this research may have immediate policy relevance, a 
key consideration has been its timeliness. Consequently, this project is based on data generated 
from a self-completed questionnaire, in preference to interview-based methods. This in turn 
dictated the use of a visual analogue scale (VAS) rather than the other techniques mentioned in 
the Introduction — an issue we will return to in the Discussion. 
 
Figure 1: The EuroQol Health State Classification System, EQ-5D. 
Mobility 
1. I have no problems walking about. 
2. I have some problems walking about. 
3. I am confined to bed. 
 
Self-care 
1. I have no problems with self-care. 
2. I have some problems washing or dressing myself. 
3. I am unable to wash or dress myself. 
 
Usual Activities 
1. I have no problems with performing my usual activities  
(e.g., work, study, leisure or family activities). 
2. I have some problems with performing my usual activities. 
3. I am unable to perform my usual activities. 
 
Pain/discomfort 
1. I have no pain or discomfort. 
2. I have moderate pain or discomfort. 
3. I have extreme pain or discomfort. 
 
Anxiety/depression 
1. I am not anxious or depressed. 
2. I am moderately anxious or depressed. 
3. I am extremely anxious or depressed. 
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The EQ-5D describes health states in terms of five dimensions: the degree of mobility, ability to 
undertake self care, ability to participate in usual activities, degree of pain/discomfort, and 
degree of pain/depression. Within each dimension there are three levels: (1) no problems, (2) 
moderate problems, and (3) extreme problems (see Figure 1). Thus each health state can be 
described by a five-digit combination relating to the relevant level within each dimension (with 
the dimensions listed in the order given above and in the figure). Together these dimensions and 
levels define 243 possible health states ranging from 11111 (no problems on any dimension - 
with value set equal to unity) to 33333 (extreme problems on all dimensions) which, together 
with ‘unconscious’ and ‘dead’ respectively (the latter set equal to zero), describe 245 states to be 
valued in a full tariff. 
 
The responder burden imposed by valuation exercises limits the number of states any one 
respondent can sensibly be asked to value directly. The construction of a tariff is therefore 
achieved by selecting a sub-set of the 245 states and using these to interpolate values, via 
regression techniques, for the entire set. To this end, three questionnaires were developed for the 
study.
1 Version A contained the ‘standard’ set of 13 health states previously used in VAS 
valuation studies (see Devlin and Williams 1999), in order to facilitate comparative analysis. 
Versions B and C represented further selections of health states from the array of 245 possible 
states, a strategy designed to give greater breadth to the observations from which the complete 
tariff of values is modelled.  Table 1 lists the states to be valued in each version of the 
questionnaire.  Respondents were asked to indicate where, on a VAS depicted as a vertical line 
marked from 100 (“best imaginable health state”) to 0 (”worst imaginable health state”), they 
considered each state was for them. 
 
Questionnaires were mailed in January 1999, with a reminder and replicate questionnaire two 
weeks later, to a non-stratified random sample of 3,000 adult New Zealanders on the electoral 
roll. An initial check confirmed the sample to be representative of the New Zealand population 
in terms of age, sex and Maori/non-Maori composition. Some 259 questionnaires were returned 
as the respondent having deceased or no longer living at the address shown on the roll. 1360 
completed questionnaires were returned - a response rate of 50% from those who received them.  
 
Table 1: The EQ-5D health states for which valuations were sought. 
Version A    Version B    Version C   
         
11211 21111 11211 11112 11211 11112 
11111 11111*  11111 11111*  11111 11111* 
21232 unconscious  21111 13311 21111 11113 
11122 12111 11133 32211 11133 11312 
11121 11112 11121 11131 11121 12111 
22233 32211 22222 32313 22222 32223 
33333 33333*  33333 33333*  33333 33333* 
33321 22323 33323 23232 33323 23232 
dead dead*  dead dead*  dead dead* 
 
Note: Health states were displayed over two pages (corresponding to the columns above) in the order listed. States 
marked * were repeated from the first page. 
                                                 
1 These are available from the authors on request. Health State preferences of New Zealanders  4 
2.2  Missing, Implausible and Unusable Data 
 
Of the 1360 completed questionnaires, 103 did not respond to the health state valuation 
questions, with a further 338 immediately excluded as being unsuitable for estimating a tariff 
according to the following criteria (see Table 2). If fewer than three states were valued, or if all 
states were given the same score, they were rejected since this was judged an implausible 
representation of a respondent’s preferences. Also excluded were data that were unusable for the 
estimation of a tariff due to problems (discussed below) arising from states 11111 and dead.  
 
Table 2: Responses classified according to reasons for exclusion. 
Total Responses:  1360 
   
minus Missing Data    
Entire data set of valuations missing:  103 
Only one or two states valued:  40 
  
minus Implausible Data   
All valued states given the same value:  46 
  
minus Unusable Data   
Dead and/or 11111 (both observations) not valued:  237 
Dead valued greater than or equal to 11111:  15 
  
Useable Responses (i.e., with at least one Xrescaled): 919 
  
 
Note: Some responses suffered from more than one of these defects;  
they are classified once only in the order that the criteria appear in the table. 
 
Since health state preferences are anchored for present purposes at dead = 0 and full health = 1, 
each respondent’s valuations (in the range 0 to 100, as above) must be normalised relative to his 
or her valuations of dead and 11111. Thus the ‘raw scores’, Xraw score, are rescaled according to 
the transformation Xrescaled = (Xraw  score – deadraw  score)/(11111raw  score – deadraw  score). Rescaled 
values (Xrescaled) that fall outside the range 0 to 1 are interpretable as belonging to states 
considered by the respondent to be worse than dead or better than full health respectively. Given 
this transformation, if a respondent does not value 11111 and/or dead or scores 11111 < dead 
then Xrescaled is either undefined or uninterpretable. Since, as noted above, 11111 and dead are 
valued twice per questionnaire, all of the respondent’s data were excluded if either state is absent 
from both pages. If absent from one page but not the other, then only the data on the defective 
page are excluded (these exclusions are not reported in Table 2). 
 
These 919 usable responses constitute the maximum sample from which a tariff of health state 
preferences can be estimated. The demographic and background characteristics of this ‘full’ 
sample are reported in Table 3, as well as, for comparison purposes, the sex, age, ethnicity and 
smoking characteristics of the New Zealand population (Statistics New Zealand 1997).  CHE Discussion Paper 180  5
Given our aim is to estimate a tariff reflecting the preferences of adult New Zealanders, the 
sample from which it is estimated ought to be as representative as possible. But, of the 
characteristics featured in Table 3, which are relevant to explaining variations in individuals’ 
health state valuations? On the basis of Dolan et al.’s (1994) findings for the United Kingdom, of 
the variables reported in Table 3, education would be expected to exert an influence on health 
state valuations, while age, sex, smoking, and employment status would not. Comparable 
research for New Zealand is currently not available, although the data collected for this study 
will allow us to systematically investigate this question in a future paper. 
 
Nevertheless, one important consideration is New Zealand’s unique ethnic makeup, in particular 
the significant Maori and Pacific Islands minorities. A priori, the ethnicity variable reported in 
Table 3 is not ruled out as being a potentially significant determinant of New Zealanders’ health 
state valuations. In particular, the possibility that Maori perceive and value health differently 
than non-Maori is based on what is widely accepted as a ‘Maori health perspective’, whare tapa 
wha, which compares health to the four walls of a house, each being necessary for symmetry and 
strength. Each wall represents a different dimension of health: taha wairua (the spiritual side), 
taha hinengaro (thoughts and feelings), taha tinana (the physical side), and taha whanau (the 
family) (Durie 1998). In this conceptualisation, physical health cannot be distinguished from 
other dimensions of well-being and the focus of QALYs on effects that are ‘health-related’ 
would be seen as an arbitrary distinction. It is also conceivable that Pacific Islands people, New 
Zealand’s other predominant minority ethnic group, perceive and value health differently than 
Maori and Pakeha/Europeans.  
 
It is clear from Table 3 that Maori and Pacific Islands people are under-represented and 
Pakeha/Europeans over-represented in the full sample. How serious a short-coming this is 
impossible to judge; however it should be borne in mind when the tariff from this sample and 
from an alternative (smaller) sample is presented later in the paper. Similarly, in the light of 
Dolan’s findings regarding the effect of education on health state valuation, the 
overrepresentation of those with higher education should also be noted. While the form of the 
education question did not allow direct comparison with Census data (and, conceivably, the 
sample interpreted the question on ‘equivalent professional qualification’ rather loosely) it seems 
clear that lower educated people are under-represented in the sample. 
 
The differences between the full sample and the 441 respondents who were excluded for the 
reasons noted in Table 2 (i.e., data that were missing, implausible or unusable), although not 
reported here, are statistically significant. The latter group tended on average to be older (56 
years compared to 47), and consequently more likely to be retired. They were also less likely to 
have continued their schooling after the minimum school-leaving age or to have a degree or 
equivalent professional qualification, and more likely to be of Maori or Pacific Islands ethnicity. 
Not surprisingly, given their responses were unusable for our purposes, they were more likely to 
have reported that they had difficulty completing the questionnaire, although they were no 
different to the full sample in the extent to which they regarded the descriptions of ‘health’ 
employed in the EQ-5D questionnaire as adequate. Health State preferences of New Zealanders  6 
Table 3: Demographic and background characteristics (averages) of the full sample, and 






Sex:    
Female 56.1  51.8 
Male 43.5  48.2 
Age:    
18-19 years  1.7  4.0 
20-29 11.6  20.7 
30-39 20.9  22.0 
40-49 22.4  18.9 
50-59 18.4  13.1 
60-69 14.8  10.2 
70-79 7.1  7.5 
80-89 2.3  3.1 
90+ 0.0  0.4 
Ethnicity:    
European or Pakeha  86.1  76.8 
Maori 7.6  10.3 
Pacific Islands
# 1.2  3.8 
Asian or ‘other’  4.2  4.4 
Main Activity:    
Employed/self-employed 62.7   
Retired 17.3   
Houseworker 11.8   
Studying 4.1   
Seeking work  1.6   
Other 2.0   
Did your education continue after the minimum school-leaving age?  
(yes): 78.3  
Do you have a degree or equivalent professional qualification?  
(yes): 42.9  
Smoking Behaviour:    
Current smoker  13.3  22.3 
Ex-smoker 31.6  21.3 
Never-smoker 54.2  48.7 
Have you experienced serious illness:    
In yourself? (yes)  28.7   
In your family? (yes)  65.2   
When caring for others? (yes)  37.5   
How did you find filling in this questionnaire?:    
Very difficult  6.6   
Fairly difficult  32.2   
Fairly easy  48.0   
Very easy  11.2   
Do you feel that the way of describing ‘health’ in this questionnaire covers all 
aspects of your health that are important to you? (yes): 70.7   
  
Notes: 
# Samoan, Cook Island Maori, Tongan and Niuean. Not all percentages sum to 100 as respondents for whom 
a response was not recorded are not reported here. 
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3.  LOGICALLY INCONSISTENT DATA 
 
The 919 useable responses can be further classified by the extent to which each exhibits ‘logical 
inconsistencies’ in the health state valuations, in the following sense. A state with a less severe 
rating on a particular dimension than another state, given its ratings on the other dimensions are 
no more severe, can be judged the ‘better’ state and therefore ought, logically, to be scored 
higher by the respondent making the comparison.
2 For example, 11111 is a better health state 
than 12111 (and all other health states — except perhaps dead, for religious reasons). Thus a 
check on the quality of the responses can be made by examining the extent to which such 
rankings are not observed in the data, that is, the number of pairwise ‘logical inconsistencies’ in 
the reported scores for each respondent. The maximum number of inconsistencies possible is 52 
for version A of the questionnaire, 54 for B and 58 for C.
3 Table 4 decomposes the full sample 
according to the number of inconsistencies exhibited in each useable response. 
 









0 189  189 
1 207  396 
2 137  533 
3 98  631 
4 56  687 
5 48  735 
6 30  765 
7 18  783 
8 17  800 
9 14  814 
10 12  826 
11-20 50 876 
21-30 22 898 
31-40 13 911 
41-50 7 918 
57 1  919 
    
 
Clearly, inconsistencies are the norm. This is not surprising since the questionnaires were self-
administered and respondents were not instructed to rank the 14 states before scoring them, as 
was the case in an interview-based administration of the same instrument for the United 
Kingdom (Dolan et al. 1994).
4 Also, arguably, for some respondents the ordinal relationships 
between health states will have been obscured by their description ‘in words’ (as a series of five 
sentences from Figure 1) rather than numbers (as they are represented in Table 1). 
                                                 
2 Dolan and Kind (1996) describe pairs of valuations that violate this logical principle as ‘primary inconsistencies’ 
and Badia et al. (1999a) describe them as ‘internal inconsistencies’. Of course, not all pairs can be ranked on this 
basis, for example, 12111 and 21111. 
3 Note that individuals with missing data are exposed to fewer potential inconsistencies. 
4 However, Dolan and Kind (1996), comparing inconsistencies between self-completed and interview administered 
VAS questionnaires, concluded that inconsistencies were more common in the latter type, which they suggested to 
be due to the former being completed by people who were more likely to be able to answer them ‘logically’ — that 
is, people who were less able to answer logically tended not to answer at all.  Health State preferences of New Zealanders  8 
The socio-demographic and background characteristics of the individuals with the greatest 
numbers of inconsistencies were qualitatively similar to the characteristics (not reported) of the 
441 respondents who had been immediately excluded from the full sample. In addition, Table 5 
presents a comparison of the characteristics for the group with 7 or more inconsistencies (n=154) 
and the group with 0-1 inconsistencies (n=396). Individuals in the former group tended on 
average to be older (51 years compared to 45) and were more likely to be retired and to smoke. 
They were also less likely to have continued schooling after the minimum school-leaving age or 
to have a degree or equivalent professional qualification, and more likely to be Maori and less 
likely to be Pakeha/European. Interestingly, they were less likely to have reported difficulty 
completing the questionnaire, which perhaps is explained by their having put less effort into it, 
or having misunderstood the nature of the task, compared to the group with fewer logical 
inconsistencies. 
 
Given 80% of the 919 useable responses exhibit logical inconsistencies (Table 4), it must be 
decided how many of these inconsistencies are acceptable for the purpose of constructing a tariff 
of health state preferences. That is, what it the appropriate sample, such that we can have 
confidence in the validity and reliability of respondents’ valuations and hence in the tariff 
derived from them? At one extreme, with as many as 57 inconsistencies, is the full sample 
(n=919). At the other extreme is a (sub-)sample restricted to individuals with no inconsistencies 
(n=189); arguably, this is the highest quality data, however it constitutes only a fifth of the 
otherwise useable responses. Relaxing the number of inconsistencies that are allowed (as 
follows) permits another six possibilities: 0-1 inconsistencies (n=396), 0-2 inconsistencies 
(n=533), 0-3 inconsistencies (n=631), 0-4 inconsistencies (n=687), 0-5 inconsistencies (n=735), 
0-6 inconsistencies (n=765). Deciding which of these constitutes the appropriate sample from 
which to estimate the tariff is essentially an arbitrary decision, although some guidance is 
provided by Ohinmaa and Sintonen (1998). 
 
Using data from a Finnish postal survey similar to ours but without rescaling (this difference is 
important, as discussed below) they tested the sensitivity of the mean values of health states 
from different samples, distinguished according to the number of inconsistencies in the 
individual responses. Compared to individuals with no inconsistencies, the mean values of health 
states were increasingly different the greater the number of inconsistencies admitted: with more 
than three inconsistencies, almost 80% of average values were statistically different (at the 5% 
significance level) from the group with no inconsistencies. Ohinmaa and Sintonen concluded 
that their estimates were seriously biased by responses with more than three inconsistencies, 
with the corollary that such responses ought to be excluded. Since “the postal method [for 
eliciting health state values] will produce significantly more inconsistencies than the VAS 
studies using interviews”
5 they recommended that “there should be some guidelines [for other 
researchers] to exclude the most inconsistent respondents from the modeled data set.” (p. 15).  
                                                 
5 This statement appears at odds with the conclusion of Dolan and Kind (1996) discussed in footnote 4 above. CHE Discussion Paper 180  9
Table 5: Demographic and background characteristics (averages) of the respondents with 
0-1 and 7+ inconsistencies respectively, and 1996 Census statistics (repeated from Table 3). 







% % % 
Sex:      
Female 54.3  55.2  51.8 
Male 45.0  44.8  48.2 
Age:      
18-19 years  2.5  2.0  4.0 
20-29 14.9
*** 5.2  20.7 
30-39 21.9  19.5  22.0 
40-49 22.5  22.1  18.9 
50-59 17.4  15.6  13.1 
60-69 12.4  22.1
** 10.2 
70-79 7.1  7.8  7.5 
80-89 1.0  5.2
** 3.1 
90+ 0.0  0.0  0.4 
Ethnicity:      
European or Pakeha  86.5
** 78.4  76.8 
Maori 7.1  12.3
* 10.3 
Pacific Islands
# 1.4  1.2  3.8 
Asian or ‘other’  4.1  6.4  4.4 
Main Activity:      
Employed/self-employed 64.1
** 52.6   
Retired 15.9  24.7
**  
Houseworker 11.6  10.4   
Studying 5.6  3.3   
Seeking work  0.8  3.3
*  
Other 2.0  5.8
**  
Did your education continue after the minimum school-leaving age?   
(yes): 86.4
*** 59.7   
Do you have a degree or equivalent professional qualification?    
(yes): 45.5
** 34.4   
Smoking Behaviour:      
Current smoker  11.4  19.5
** 22.3 
Ex-smoker 28.8  31.8  21.3 
Never-smoker 58.6
** 47.4  48.7 
Have you experienced serious illness:      
In yourself? (yes)  23.2  32.5
*   
In your family? (yes)  64.9  61.0   
When caring for others? (yes)  34.9  36.4   
How did you find filling in this questionnaire?:     
Very difficult  7.1  9.7   
Fairly difficult  35.4
** 24.0   
Fairly easy  45.2  49.4   
Very easy  10.9  13.6   
Do you feel that the way of describing ‘health’ in this questionnaire covers all    
aspects of your health that are important to you? (yes): 70.5  70.1   
   
Notes: 
# Samoan, Cook Island Maori, Tongan and Niuean. Not all percentages sum to 100 as respondents for whom 
a response was not recorded are not reported here. 
*, 
**, 
***, denotes the proportion is significantly larger than its 
counterpart in the other sample at the 5%, 2% and 0.2% levels of significance respectively. Health State preferences of New Zealanders  10 
No such sensitivity in the mean values of health states is evident in our data. In fact, we find the 
opposite result: respondents’ mean valuations are very robust to the number of inconsistencies 
admitted. Table 6 reports the mean rescaled values for respondents grouped according to the 
number of inconsistencies (where an asterisk denotes a statistically significant difference, via a t-
test, in the mean value compared to the group with no inconsistencies). As can be seen, almost 
all of our mean values of Xrescaled are statistically the same across groups.  
 
We believe that the absence of an apparent threshold in our data, compared to Ohinmaa and 
Sintonen’s threshold at three inconsistencies, can be explained by our using rescaled values 
instead of raw scores, as they did.
6 Given that rescaled data are the appropriate data for 
estimating a tariff, and given that (explained below) t-values are not invariant to the data 
transformations introduced by rescaling (or not), then Ohinmaa and Sintonen’s t-tests and the 
inferences they derive are invalid. 
 
The difference between t-tests based on rescaled data (as reported here) and t-tests from raw data 
(as reported by Ohinmaa and Sintonen) can be appreciated by considering the usual t-statistic 
formula, t = (X  0 − X  a)/ s0
2 /n0 + sa
2 / n0 , where X  0  andX  a are the mean health state values for 
the group with no inconsistencies and its comparator group respectively, s0
2 and sa
2 are their 
variances and n0 and na their sample sizes. Both X  0  andX  a depend (by design) on whether the 
health state values from which they are calculated are rescaled or not, as do s0
2 and sa
2, but the 
transformation alters their ratio in the t-statistic. In other words, the raw data and the rescaled 
data produce different t-statistics and hence different inferences.
7 Hence, given that rescaling is 
necessary for estimating a tariff, Ohinmaa and Sintonen’s discovery of an inconsistency 
threshold, based as it is on raw data only, is invalid, whereas our finding is valid that a threshold 
does not exist. 
 
This lends prima facie support for the full sample (n=919) being the ‘default’ for estimating a 
tariff.
8 The full sample also has the appeal of having arisen ‘naturally’, rather than by researcher 
decree as to what is and what is not an acceptable number of inconsistencies in a respondent’s 
valuations. However, two other characteristics of the mean values reported in Table 6 suggest 
                                                 
6 Ohinmaa and Sintonen did this because they wanted to maximise the size of their data set by including 
respondents who did not value dead which, if they rescaled, would have had to be excluded (as ours were). 
7 Indeed, we believe that using raw data systematically biases the results in favour of finding significant mean value 
differences. This is because the estimated variances relative to the means (this relationship is the basis of the t-test) 
are likely to be smaller using raw data than if rescaled data are used. This property of the variances can be inferred 
heuristically (somewhat unsatisfactorily, we concede) by considering the sample ranges. Without scaling the 
maximum possible range that a health state value can have is 100 – 0 = 100, with the mean between these extremes. 
With scaling this range has the potential to increase to 100 – -99 = 199. That is, at one extreme, if the respondent 
(raw) scores dead = 0, 11111 = 1 and the state to be rescaled is scored 100, then the rescaled value is 100. At the 
other extreme, if dead = 99, 11111 = 100 and the state to be rescaled is 0, then the rescaled value is -99. If we are 
able to infer from this heuristic illustration that the variance relative to the means will be smaller using raw data, 
compared to rescaled data, then there is a greater likelihood of rejecting the null hypothesis that the sample means 
are the same, since the calculated t-value will be relatively large. 
8 This would be consistent with the principle agreed to at the Barcelona meeting of the EQ-net project in January 
1999 that the number of exclusions should be minimised. CHE Discussion Paper 180  11
that, in fact, there are systematic differences between the groups such that not all of them belong 
together in a single sample. 
 
One, the rankings (shown in parentheses in Table 6) increasingly disagree as the number of 
inconsistencies increase. Two, the number of inconsistencies in the mean Xrescaled values vary (in 
general, increase) across the groups (where, in the table, inconsistent states have a box around 
their mean value): zero for the group with no (individual) inconsistencies; zero for the group 
with one inconsistency; two for the group with two inconsistencies;
9 three for the group with 
three;
10 six for the group with four;
11 three for the group with five;
12 four for the group with 
six;
13 and 14 for the group with seven-or-more inconsistencies. 
 
Table 6: Mean rescaled health state values (and rankings) grouped according to the 
number of inconsistencies in the individual respondent scores. 
  Mean values of Xrescaled 




















11211 0.7931  0.7991  (1)  0.7955  (1)  0.8675  (1)  0.8059  (1)  0.7790  (1)  0.8536  (1)  0.9688  (1) 
21111 0.7588  0.7280
*  (2)  0.6972
*  (4)  0.7370  (3)  0.6239  (5)  0.6446
*  (4)  0.7874  (2)  0.6915  (6) 
11112 0.7514  0.7097
*  (4)  0.7106  (3)  0.7207  (4)  0.7064  (2)  0.7405  (2)  0.7309  (6)  0.9828  (2) 
11121 0.7441  0.7274  (3)  0.7186  (2)  0.7846  (2)  0.6733  (4)  0.7310  (3)  0.7838  (3)  0.8467  (3) 
12111 0.7057  0.6871  (5)  0.6624  (5)  0.6553  (5)  0.6978  (3)  0.6120  (5)  0.6748  (5)  0.5306  (9) 
11131 0.5244  0.4729  (7)  0.4534  (6)  0.4467  (8)  0.3506
*  (10) 0.5300  (7)  0.3852  (9)  0.8241  (4) 
11122 0.5203  0.5015  (6)  0.3478  (9)  0.6151  (6)  0.4827  (6)  0.5552  (6)  0.5502  (6)  0.6762  (7) 
13311 0.4557  0.4275  (8)  0.3926  (8)  0.3113
*  (9)  0.3579  (9)  0.3424  (10) 0.3460  (10)  0.5855  (8) 
11113 0.4121  0.4200  (9)  0.3979  (7)  0.3043  (11) 0.3864  (8)  0.3538  (9)  0.4409  (7)  0.5167  (10)
22222 0.3752  0.3637  (11) 0.3293  (11)  0.3057  (10) 0.3418  (11) 0.2506  (14) 0.2860  (12)  0.3992  (13)
11312 0.3636  0.3744  (10) 0.3464  (10)  0.2767  (12) 0.4173   (7)  0.2604  (13) 0.2854  (13)  0.4176  (12)
32211 0.3360  0.2595
*  (12) 0.2143  (12)  0.2653  (13) 0.1608
* (15) 0.2918  (12)  0.2978  (11)  0.0104  (22)
21232 0.2923  0.2402  (13) 0.1191  (15)  0.4510
* (7)  0.3159  (12) 0.4910  (8)  0.4333  (8)  0.4494  (11)
32313 0.1716  0.1252  (17) 0.1418  (13)  0.0640  (18) -0.0315
* (21) 0.0599  (17) 0.1499  (14)  0.1093  (19)
11133 0.1667  0.1538  (14) 0.1327  (14)  0.0130  (19) 0.1555  (16) 0.0608  (16) 0.0858  (19)  0.1514  (17)
22323 0.1656  0.1253  (16) -0.0385  (20)  0.2365  (14) -0.0434 (22) 0.0175  (18) 0.0900  (18)  0.7706  (5) 
22233 0.1506  0.1362  (15) -0.0080  (19)  0.2160  (15) 0.1940  (14) 0.2953  (11) 0.1258  (15)  0.2313  (16)
32223 0.1435  0.1061  (19) 0.1167  (16)  -0.0379  (21) 0.2178  (13) -0.0297
* (21) 0.1076  (16)  0.2565  (14)
33321 0.1320  0.1045  (20) -0.0404  (21)  0.0950  (16) 0.0721  (17) 0.1919  (15) 0.0693  (20)  -0.0854 (24)
23232 0.1122  0.1165  (18) 0.1034  (17)  0.0097  (20) 0.0633  (19) -0.0009  (20) 0.0194  (22)  0.0567  (21)
uncon. 0.0326 0.0308  (21) -0.0862  (23)  0.0728  (17) -0.1645  (24) 0.0132  (19) 0.1034  (17)  -0.0540  (23)
33323 0.0280  -0.0011  (22) 0.0081  (18)  -0.1230 (23) 0.0711  (18) -0.0872 (23) -0.0255  (24)  0.2393  (15)
33333b -0.0622 -0.0835  (24) -0.0940  (24)  -0.1108 (22) -0.0634  (23) -0.0585 (22) -0.0274  (23)  0.1246  (18)
33333a -0.0635  -0.0856  (23) -0.0854  (22)  -0.1582  (24) 0.0074  (20) -0.0971  (24) 0.0447  (21)  0.0958  (20)
                     
Notes: Figures in parentheses are rank orders and 
* denotes that the difference in the mean value, compared to the 
group with no inconsistencies, is statistically significant at the 5% level. 33333a and 33333b distinguish the two 
valuations for this state (i.e., from the two page referred to in Table 1). Boxes around values signify inconsistent 
states (see footnotes 9-13). 
                                                 
9 33323 is valued above 33321 and 22323. 
10 33333b above 33323, 22233 above 11133 and 21232 above 11131. 
11 33323 and 33333a above 22323 and 32313, 22233 above 11133 and 32223 above 32211.  
12 33333b above 33323 and 22233 above 11133 and 22222. 
13 33333a above 33323 and 23232, 22233 above 11133 and 21232 above 11131. Health State preferences of New Zealanders  12 
These results imply a degree of systematic, as opposed to purely idiosyncratic, inconsistency in 
the groups (other than the ones with zero and one inconsistency respectively) since were they 
purely idiosyncratic in nature they would be expected to ‘cancel each other out’ when combined 
(i.e., averaged) in the groups. Thus the (sub-)sample with 0-1 inconsistencies (n=396) is the 
leading candidate as an alternative (and comparator) to the full sample (n=919). Bearing in mind 
our earlier discussion of the potential importance of ethnic differences between respondents, it 
turns out too that this sample, of the seven possibilities noted earlier, is most representative of 
the ethnic composition of the New Zealand population (while still under-representing Maori and 
Pacific Islands people). Furthermore, since this sub-sample constitutes the opposite extreme to 
the admission of all inconsistencies, as in the full sample, it permits us to explore the differences 
between the two tariffs that are produced from each. We proceed, therefore, in the remainder of 
the paper, to estimate a tariff of health state preferences from the full sample (n=919) and 
another from the sub-sample with 0-1 inconsistencies (n=396). 
 
4. STATISTICAL  METHODS 
 
Our approach is based on the same model and generalised least-squares regression technique as 
Dolan (1997). These two aspects are discussed in turn.  
 
4.1 The  Model 
 
Each of the 22 health states for which we have data (see Table 6), but not including 
‘unconscious’, can be represented by dummy variables designed to capture possible independent 
and interaction effects across the five dimensions of the EQ-5D health state classification system. 
Also, each dimension can be represented as either linear or non-linear in its three levels. Figure 2 
(adapted from Dolan, pp. 1099-1100) lists the available dummies, which are grouped in five sets. 
Like Dolan, we do not have a theoretical model to direct how these dummies ought to be 
combined in an equation suitable for estimation. Nonetheless we considered it better to include 
all or none of the dummies from a particular set in the equations we experimented with, rather 
than ‘mix-and-match’ from different sets. 
 
Since the EQ-5D system values health states other than full health as negative deviations from a 
value of unity (since 11111 = 1), Xrescaled can be represented as 1 minus the appropriate (linear) 
combination of dummy variables and their coefficients (to be estimated).
14 However, a constant 
of unity corresponds to transforming the dependent variable to 1–Xrescaled (of which, accordingly, 
higher values correspond to more severe health states). Thus we experimented with the nine 
                                                 
14 For an illustration of this calculation readers are invited to skip forward to Table 7. CHE Discussion Paper 180  13
specifications below of the general form:
15 1–Xrescaled = constant + Dβ + error term (where D is 
the row vector of dummies (as below) and β  the  column vector of coefficients). Although 
transforming the dependent variable to 1–Xrescaled implies constant = 0, this restriction was not 
imposed - since were it invalid the estimates of β would be biased (and, possibly, the R
2 statistics 
outside their usual range of 0 to 1). (As happens, however, the constant estimates are 
significantly different from zero - the interpretation of which we consider in the Results below.) 
 
Specification (1): (MO, SC, UA, PD, AD) - i.e., set 1. 
Specification (2): (MO, SC, UA, PD, AD) and N3 - set 1 plus N3. 
Specification (3): (MO, SC, UA, PD, AD) and (M2, S2, U2, P2, A2) - sets 1 and 2. 
Specification (4): (MO, SC, UA, PD, AD), (M2, S2, U2, P2, A2) and N3 - sets 1 and 2 plus N3. 
Specification (5): (MO, SC, UA, PD, AD), (M2, S2, U2, P2, A2) and (MOSC, MOUA, MOPD, 
MOAD, SCUA, SCPD, SCAD, UAPD, UAAD, PDAD) - sets 1, 2 and 3. 
Specification (6): (MO, SC, UA, PD, AD) and (MOSC, MOUA, MOPD, MOAD, SCUA, SCPD, 
SCAD, UAPD, UAAD, PDAD) - sets 1 and 3. 
Specification (7): (F11, F21, F31, F41) and (F13, F23, F33, F43, F53) - sets 4 and 5. 
Specification (8): (MO, SC, UA, PD, AD), (F11, F21, F31, F41) and (F13, F23, F33, F43, F53) 
- sets 1, 4 and 5. 
Specification (9): (MO, SC, UA, PD, AD) and (F13, F23, F33, F43, F53) - sets 1 and 5. 
 
Specification (1) treats movements on a particular dimension between levels 1 and 2 and levels 2 
and 3 respectively as having identical effects on health state valuations, while (2) recognises an 
additional effect, captured by the N3 variable, arising from any of the dimensions being at level 
3 (extreme problems). Specifications (3), (4) and (5) allow for non-linearities between levels, 
with (4), the so-called “main effects” models augmented with the N3 variable, the basis of the 
equation from which Dolan estimated his tariff. As well, specification (5) allows for interaction 
effects between dimensions, as does (6). Specification (7) consists entirely of dummies that 
simply count the number of dimensions at levels 1 and 3 respectively, without distinguishing 
between dimensions (e.g., 31111 and 11113 are equivalent). As such it is not a serious contender 
for estimating a tariff since a priori we expect the dimensions to have unique effects on 
preference values. Specifications (8) and (9) overcome this potential shortcoming by augmenting 
the dummies in (7) with others that distinguish between particular dimensions. 
 
Our principal criterion for discriminating amongst the estimates of the nine specifications is that 
the tariff of health state preferences that is produced from it be logically consistent. This imposes 
several restrictions on the specifications’ coefficient point estimates that are discussed in the 
Results. 
                                                 
15 Other obvious combinations, such as (M2, S2, U2, P2, A2) with (F13, F23, F33, F43, F53), are ruled out because 
they are collinear. Health State preferences of New Zealanders  14 
Figure 2: Dummy variables available to model dependent variable 1–Xrescaled 
Set 1: Dummies to represent the (assumed equal) move between all three levels. 
 
  MO  1 if mobility is level 2; 2 if mobility is level 3; 0 otherwise 
  SC  1 if self-care is level 2; 2 if self-care is level 3; 0 otherwise 
  UA  1 if usual activities is level 2; 2 if usual activities is level 3; 0 otherwise 
  PD  1 if pain/discomfort is level 2; 2 if pain/discomfort is level 3; 0 otherwise 
  AD  1 if anxiety/depression is level 2; 2 if anxiety/depression is level 3; 0 otherwise 
 
Set 2: Dummies to represent the move from level 2 to level 3. (This allows the effect of the move from 
level 1 to level 2 to be different from the effect of the move from level 2 to 3.) 
 
  M2  1 if mobility is level 3; 0 otherwise 
  S2  1 if self-care is level 3; 0 otherwise 
  U2  1 if usual activities is level 3; 0 otherwise 
  P2  1 if pain/discomfort is level 3; 0 otherwise 
  A2  1 if anxiety/depression is level 3; 0 otherwise 
 
Set 3: Dummies to allow for possible (first order) interactions between dimensions. 
 
  MOSC  The product of MO and SC 
  MOUA  The product of MO and UA 
  MOPD  The product of MO and PD 
  MOAD  The product of MO and AD 
  SCUA  The product of SC and UA 
  SCPD  The product of SC and PD 
  SCAD  The product of SC and AD 
  UAPD  The product of UA and PD 
  UAAD  The product of UA and AD 
  PDAD  The product of PD and AD 
 
Set 4: Dummies to count for the number of dimension(s) that are at level 1. 
 
  F11  1 if the health state contains 1 dimension at level 1; 0 otherwise 
  F21  1 if the health state contains 2 dimensions at level 1; 0 otherwise 
  F31  1 if the health state contains 3 dimensions at level 1; 0 otherwise 
  F41  1 if the health state contains 4 dimensions at level 1; 0 otherwise 
 
Set 5: Dummies to count the number of dimension(s) that are at level 3. 
 
  F13  1 if the health state contains 1 dimension at level 3; 0 otherwise 
  F23  1 if the health state contains 2 dimensions at level 3; 0 otherwise 
  F33  1 if the health state contains 3 dimensions at level 3; 0 otherwise 
  F43  1 if the health state contains 4 dimensions at level 3; 0 otherwise 
  F53  1 if the health state contains 5 dimensions at level 3; 0 otherwise 
 
Also, in keeping with Dolan: “one further dummy that represents whether any of the dimensions are at 
level 3.” 
 
  N3  1 if any dimension is level 3; 0 otherwise 
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4.2 Regression  Technique 
 
The nine specifications outlined above were estimated as ‘random effects’ models using the 
LIMDEP programme, version 6 (Greene 1991). The defining feature of this model (in its ‘one 
factor’ version) is its error term has two parts: a traditional error that is unique to each 
observation of the dependent variable (1–Xrescaled) — irrespective of the individual in the sample 
whom it concerns — and another that is peculiar to each individual — that represents the extent 
to which his/her intercept differs from the overall intercept of the model. The purpose of the 
second component is to allow individual-specific effects for explaining the variation in the 
dependent variable without having to resort to a dummy variable for each individual (the latter is 
a ‘fixed effects’ model — e.g., see Greene 1991, pp. 298-9).
16 Thus a given individual who, 
because of background or idiosyncratic factors, has a tendency to, say, under-value health states 
relative to other individuals’ valuations will, due to the second error component, have his/her 
estimated intercept value increased without affecting the intercepts of the other sample members. 
 
5. REGRESSION  RESULTS 
 
The estimates of the nine specifications for the full sample (n=919) and the sub-sample with 0-1 
inconsistencies (n=396) are reported in Tables A1 and A2 in the Appendix. The R
2s for the latter 
sample are all around 70%, which is a very good fit. For the full sample they are less impressive 
(around 9%), which perhaps is not surprising given the potentially disparate nature of the data 
set as a result of the full complement of inconsistencies being admitted.  
 
Notwithstanding very different fits over the two samples, the signs on the estimated coefficients 
are in general agreement. Moreover, in all six of the alternative sub-samples that we rejected in 
the Data section (i.e., 0, 0-2, 0-3, 0-4, 0-5 and 0-6 inconsistencies respectively), the signs and 
significance of the coefficients were mostly replicated.
17 This confirmed our earlier conclusion 
that, empirically, a threshold in terms of the number of inconsistencies does not exist. As before, 
this is in contrast to Ohinmaa and Sintonen (1998, p. 12), who, upon estimating specification (3) 
(recall, with unscaled data) found three inconsistent states to be the maximum number of 
inconsistencies to not significantly affect the estimates. 
 
As noted in the previous section, choosing between the nine estimated equations hinges on the 
logical consistency of the tariffs that are generated from their point estimates. For the n=919 
sample, only specification (1) satisfies this criterion. For the n=396 sample, specifications (1), 
(2) and (7) satisfy it; however (2) is the preferred equation since, as discussed earlier, (7) was not 
a serious contender for estimating a tariff and (1) is encompassed by (2). Furthermore, all of the 
                                                 
16 Given that many of the responses in our data set are incomplete, that is, not all health states in the questionnaire 
were scored, an advantage of using LIMDEP is that each individual is not required to have the same number of 
observations. 
17 With R
2s ranging from 78% to 40%. These estimation results are available from the authors on request. Health State preferences of New Zealanders  16 
constants are statistically significant (despite, as noted in the previous section, the theory 
suggesting they ought not to be).  
 
How do the logical inconsistencies in the rejected specifications manifest themselves in the 
estimates reported in Tables A1 and A2? With respect to the full sample, specification (2) is 
disqualified for estimating a tariff because the insignificant UA coefficient dictates that two 
health profiles with levels 1 and 2 on this dimension respectively, and levels in common for the 
other four dimensions, are valued the same.
18 Specification (3) is disqualified because the 
negative S2 coefficient is absolutely larger than the SC coefficient, which implies that increasing 
severity from level 1 to 2 on this dimension (self-care) decreases Xrescaled (as it should) yet, 
perversely, increases it from level 2 to 3. Similarly, specification (4)’s negative UA coefficient 
implies that going from level 1 to 2 (i.e., “no problems” to “moderate problems”) increases 
Xrescaled. The inconsistencies in specifications (5) are (6) arise, broadly-speaking, from the 
relative magnitudes and opposite signs of the coefficients on the interaction dummies (i.e., set 3). 
Finally, in general, for specifications (7), (8) and (9) to produce logically consistent tariffs the 
coefficients on dummies F11 to F41 (set 4) must be monotonically decreasing, while the 
coefficients on F13 to F53 (set 5) must be increasing — which, clearly, they are not. Similar 
arguments apply to the six equations disqualified for the sub-sample (n=396). 
 
The statistical significance of the constants in the preferred equations poses a challenge for their 
interpretation. [As noted in the previous section, theoretically they ought to be zero because 
when the dummies are set to zero (corresponding to state 11111, valued at unity) then 1–Xrescaled 
= constant, which rearranges to Xrescaled = 1 – constant.] Dolan (1997), who, like us, obtained a 
positive constant, suggests two possible approaches.  
 
The first is practical: divide the equations, that is, their coefficients, by 1 – constant when 
calculating the tariffs. We found, however, that compared to the tariffs (detailed in the following 
section) that were generated without this transformation, the differences between the tariff 
values and respondents’ mean values increased significantly — which we considered to be 
counter-productive to our objective of mirroring respondents’ health state preferences. 
“Alternatively [and the approach we have adopted here], given that by definition the value of 
11111 [is] 1, we could interpret the intercept as representing any move away from full health. 
Thus, [it] could represent a discontinuity in the model between level 1 and level 2 in much the 
same way as the ‘N3’ term represents a discontinuity between level 2 and level 3.” (p. 1104). 
Accepting this interpretation, in the following section two tariffs of health state preferences are 
calculated from n=919’s equation (1) and n=396’s equation (2).  
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6. THE  TARIFFS 
 
Two tariffs were calculated from the equations reproduced below from Tables A1 and A2 in the 
Appendix — here with the dependent variable reinstated as X rescaled. Both tariffs for all 244 
states, including unconscious (the average of the reported rescaled values), are reported in Table 
A3 in the Appendix. Table 7 illustrates the arithmetic by which these tariff values are calculated. 
 
Equation (1) from n=919 (the full sample):  
Xrescaled = 1 – 0.2254 – 0.1026MO – 0.0894SC – 0.0346UA – 0.1046PD – 0.1127AD  
 
Equation (2) from n=396 (0-1 inconsistencies):   
Xrescaled = 1 – 0.2041 – 0.0753MO – 0.0714SC – 0.0136UA – 0.0798PD – 0.0920AD – 0.2165N3 
 
The relative importance to respondents (on average) of the five EQ-5D dimensions is revealed 
by the relative magnitudes of the dummy coefficients. In both equations anxiety/depression (AD) 
comes ahead of pain/discomfort (PD), followed by mobility (MO), then self-care (SC) and, 
finally, usual activities (UA). This ordering is not too dissimilar to Dolan’s (1997), although his 
preferred equation, specification (4), recognises differences in the effects of moving between the 
three levels. For the movement from level 1 to 2 Dolan’s ranking was: pain/discomfort, self-care, 
anxiety/depression, mobility, and usual activities; and for the move from level 2 to 3 it was: 
pain/discomfort, mobility, anxiety/depression, self-care, and usual activities. 
 
Table 7: Illustration of how the tariff value for state 21232 is calculated using equation (2) 
from n=396. 
  Full health (11111) =   1.000 
    
minus  Constant term =  0.2041 
minus Mobility  (MO): level 2 =   1 × 0.0753 
minus Self-care  (SC): level 1 =   0 × 0.0714 
minus  Usual activities (UA): level 2 =   1 × 0.0136 
minus Pain/discomfort  (PD): level 3 =   2 × 0.0798 
minus Anxiety/depression  (AD): level 2 =  1 × 0.0920 
minus  Any dimension at level 3 (N3) =  1 × 0.2165 
    
equals  Tariff value for state 21232 =  0.239 
    
 
The 22 tariff values for which we have direct valuations from the survey are of particular interest 
here. A comparison (see Table 8) with the means of respondents’ actual valuations provides a 
direct check of how well the tariffs approximate respondents’ values. As summarised by the 
mean absolute differences, the full sample’s equation (1) differs from the mean values to a 
greater extent than the sub-sample’s equation (2). Although over two-thirds of the differences for 
the n=396 sample are smaller than 0.05, as a proportion of the mean value, some of them are Health State preferences of New Zealanders  18 
large (e.g., –142% for state 33323). As evidenced by the reported Pearson correlation 
coefficients (where r = 1 for perfect positive correlation), the sub-sample’s equation (2) tariff 
values are more closely (linearly) correlated with the corresponding mean values than the full 
sample’s equation (1). 
 
Although both tariffs in their entirety (Table A3) are closely related (r = 0.94), they are 
different.
19 In particular, the n=919 tariff values are higher than the n=396 values for 206 of the 
244 states. This is explained by all of these states having at least one dimension at level 3, which 
for n=396’s equation (2) generates an additional decrement from state 11111=1 due to the 
variable N3. On the other hand, in the the n=919 tariff unconscious has a small negative value 
(i.e., worse than dead) and a positive value in the other tariff (however these values are not 
derived from equations (1) and (2), instead they are sample averages). Finally, in both tariffs the 
same six states have negative values: 23333, 32333, 33133, 33233, 33323, 33333. 
 
Table 8: Comparisons of tariff values with mean reported values. 














(% of mean value)
11211 0.740 0.834  -0.094  (-11%)  0.782 0.796  -0.014  (-2%) 
11121 0.670 0.754  -0.084  (-11%)  0.716 0.735  -0.019  (-3%) 
21111 0.672 0.716  -0.044  (-6%)  0.721 0.743  -0.022  (-3%) 
11112 0.662 0.769  -0.107  (-14%)  0.704 0.730  -0.026  (-4%) 
12111 0.685 0.655 0.030  (5%) 0.725 0.696  0.029  (4%) 
11122 0.557 0.527 0.030  (6%) 0.624 0.511  0.113  (22%) 
11312 0.593 0.354 0.239  (67%) 0.460 0.369  0.091  (25%) 
22222 0.331  0.35 -0.019  (-6%)  0.464 0.369  0.095  (26%) 
11131 0.565 0.541 0.024  (5%) 0.420 0.496  -0.076  (-15%) 
13311 0.527 0.438 0.089  (20%) 0.409 0.440  -0.031  (-7%) 
11113 0.549 0.412 0.137  (33%) 0.395 0.416  -0.021  (-5%) 
32211 0.445 0.221  0.224  (102%)  0.344 0.295  0.049  (17%) 
11133 0.340 0.129  0.211  (164%)  0.236 0.160  0.076  (47%) 
21232  0.315  0.31  0.005 (2%)  0.239  0.266  -0.027 (-10%) 
22323 0.183 0.218  -0.035  (-16%)  0.142 0.146  -0.004  (-3%) 
33321 0.217 0.059  0.158  (268%)  0.179 0.118  0.061  (52%) 
32313 0.185 0.115 0.070  (61%) 0.146 0.146  0.000  (0%) 
22233 0.113 0.152  -0.039  (-25%)  0.076 0.143  -0.067  (-47%) 
32223 0.115 0.121  -0.006  (-5%)  0.080 0.124  -0.044  (-36%) 
23232 0.137 0.078 0.059  (75%) 0.096 0.115  -0.019  (-16%) 
33323 -0.009 0.032  -0.041  (-127%)  -0.005 0.012  -0.017  (-142%) 
33333  -0.113  -0.05  -0.066 (141%)  -0.085  -0.074  -0.011 (15%) 
          




r = 0.92 
  
r = 0.98 
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7.  DISCUSSION AND CONCLUDING REMARKS 
 
As explained in the Data section, the health state valuations in the present study were elicited via 
a visual analogue scale (VAS). Several caveats apply to the use and interpretation of values 
derived in this manner. One arises from the requirement that the duration of the state being 
valued be specified. Respondents were asked to “imagine that it will last for one year. What 
happens after that is not known and should not be taken in to account.” Gudex and Dolan (1995) 
have shown that respondents’ valuations can be affected by the period of duration that is 
specified. 
 
Another concern is the possibility that respondents may be unwilling to use values at or near the 
extremes of the VAS continuum (0 and 100) for scoring states. Badia et al. (1999b), comparing 
valuation approaches for EQ-5D health states, found that considerably more states were rated 
worse than dead using time trade-off (TTO) than using VAS and that “... VAS values were 
compressed into a much tighter valuation space than TTO values” (p. 309). On the other hand, 
they confirmed the general finding in the literature that, notwithstanding the problems associated 
with VAS, it is more feasible and reliable than TTO.  
 
Compared to both the VAS and TTO, the standard gamble approach is regarded by some to be 
the ‘gold standard’, because of its theoretical foundations and indirect approach to valuations 
(notwithstanding its implementation shortcomings). It is well known that VAS values are 
theoretically inconsistent with the ‘utility under uncertainty’ provisions of von Neumann and 
Morgenstern expected utility theory (Drummond et al. 1997, Sloan 1995). In practical terms, the 
values generated for given health states are not invariant to these three methods (Sloan 1995). 
Hence, comparisons between our tariff and the UK tariff published by Dolan et al. (1995) are of 
little relevance, since the latter is based on TTO interviews.
20 
 
At just 50%, the response rate to the questionnaire on which the present study is based may be 
considered low, although it is close to that experienced in similar research internationally (see 
Brooks 1996, Bjork and Norinder 1999). This is likely to be related to the responder burden 
imposed by the valuation task. Although self-completed VAS-based questionnaires are widely 
used internationally, and a relatively inexpensively means of undertaking large-scale valuation 
exercises, it is possible that, as Bjork and Norinder (p. 123) have suggested, health state 
valuation is “... too complicated for this approach.” 
 
A related concern is the quality of the data generated by the questionnaire. At the start of the 
analysis almost a third of responses had to be rejected for a variety of reasons (the most common 
                                                 
20 A study is currently underway in the UK using a survey instrument and research protocol similar to that reported 
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being failure to score state 11111 or dead on the VAS — see Table 2). Fortunately, exclusions 
on these grounds did not appear to seriously compromise the representativeness of the sample in 
terms of broad demographic characteristics (see Table 3). However, whether individuals who did 
not respond to the questionnaire, or who did so inadequately, differed systematically in terms of 
their health state preferences from those who did respond is unknown.  
 
In addition, and a central theme of the paper, 80% of the usable responses exhibited at least one 
logical inconsistency (see Table 4). Again, given the responder burden, this and the previous 
statistic are perhaps not surprising. But they do give rise to questions about the ability of 
ordinary members of the public to undertake the valuation task unaided. The inconsistency rate 
for the present sample is considerably higher than the 9.3% rate reported by Dolan and Kind 
(1996) for a self-completed VAS postal survey in the UK and also higher than the 26% reported 
by Badia et al. (1999a) for an interview-administered VAS on a Catalan sample. The highest 
reported rate of inconsistency is 88% from a self-completed postal VAS survey in the US 
(Johnson et al. 1998). However, direct comparisons of these rates is problematic given the 
different approaches to data exclusions prior to analysis; for example, Badia et al. (1999a) 
exclude some inconsistency ‘types’ which are included in our analysis.
21 While Badia et al. 
conclude that the inconsistencies they analysed did not affect rankings in their final tariff of 
values, this was not the case for the present data set.  
 
There are therefore unresolved methodological questions relating to the treatment of logical 
inconsistencies in respondents’ valuations. Our approach was to use two samples at opposite 
extremes — to admit all inconsistencies (n=919) and to admit none or one (n=396). As discussed 
in the previous section, the resulting tariffs are different. Therefore we believe that there is merit 
in reporting the effect on results of methodological decisions such as this that rest heavily on 
researcher judgments. The air of precision leant to tariffs by the listing of a single value per state 
may be misleading because of the possibility of alternative tariffs.  
 
An implication for the practice of economic evaluation is that health state values used in CUA 
should be subjected to careful sensitivity analysis — gauging the effects of using alternative 
tariffs — in the same way as any other uncertain but important variable. We recommend that 
New Zealand analysts proposing to use the values reported here test the effects on their results of 
using values from both tariffs and consider these alongside the results produced when the UK 
tariff (or others) is employed. 
 
                                                 
21 Badia et al. excluded individuals “... if they valued any health state higher than the logically best health state 
(11111)” (p. 944). They did not provide their reasons for treating these inconsistencies differently from the ones 
they analysed, nor did they report how many exclusions were on these grounds.  CHE Discussion Paper 180  21
We note that the existing literature exploring issues arising from inconsistency in health state 
valuation (e.g. Dolan and Kind 1996, Ohinmaa and Sintonen 1998, Badia et al. 1999a) appears 
to focus exclusively on data generated from the EQ-5D health state classification system. Yet 
other systems are also likely to suffer from this problem, especially those with more dimensions 
and/or levels, such as the HUI mentioned at the beginning of the paper.  
 
A significant research territory remains to be explored in New Zealand in relation to health state 
valuations. Data generated for this study will allow us, in future papers, to explore the extent to 
which the EQ-5D health state classification system captures all the aspects of health considered 
important by our sample of New Zealanders, and to investigate the extent to which valuations 
can be explained by their socio-demographic characteristics. A key issue to explore in future 
research is the health state valuations of Maori, and the adequacy of the EQ-5D in describing 
Maori health perspectives. Furthermore, the features of the data set discussed above suggest that 
a study of the New Zealand general public using interview-based, indirect approaches (as an 
alternative to the methods used in the current study) would be worthwhile. Given the importance 
of the resource allocation decisions this sort of research may inform, there is an urgent 
requirement for the development of a base of New Zealand evidence on these and wider 
questions about health state preferences. Health State preferences of New Zealanders  22 
Appendix  
Table A1: Estimates of specifications (1) - (9) for the full sample (n=919). 
Dummy Specification 
variable  (1) (2) (3) (4) (5) (6) (7) (8) (9) 
































































































    









    







    








    








    




     





   






   






   




   





   






   





   




   




   




   



















































































0.08 0.09 0.08 0.09 0.09 0.09 0.09 0.09 0.09 
Notes: Figures in parentheses are t-values and 
♣ denotes insignificance at the 5% level. CHE Discussion Paper 180  23
Table A2: Estimates of specifications (1) - (9) for the sample with 0-1 inconsistencies (n=396).
 
Dummy Specification 
variable  (1) (2) (3) (4) (5) (6) (7) (8) (9) 


























































































    








    






    







    







    




     





   






   






   




   





   




   




   




   




   




   









































































0.68 0.71 0.68 0.72 0.73 0.71 0.71 0.73 0.72 Health State preferences of New Zealanders  24 
Notes: Figures in parentheses are t-values and 
♣ denotes insignificance at the 5% level CHE Discussion Paper 180  25





























11111 1.000 1.000  0.000  12133 0.251 0.164  0.086  13232 0.239 0.171  0.068 
11112 0.662 0.704  -0.042  12211 0.651 0.711  -0.060  13233 0.127 0.079  0.047 
11113 0.549 0.395  0.154  12212 0.538 0.619  -0.081  13311 0.527 0.409  0.117 
11121 0.670 0.716  -0.046  12213 0.425 0.310  0.115  13312 0.414 0.317  0.096 
11122 0.557 0.624  -0.067  12221 0.546 0.631  -0.085  13313 0.301 0.225  0.076 
11123 0.445 0.316  0.129  12222 0.433 0.539  -0.106  13321 0.422 0.330  0.092 
11131 0.565 0.420  0.146  12223 0.321 0.231  0.090  13322 0.309 0.238  0.072 
11132 0.453 0.328  0.125  12231 0.441 0.335  0.106  13323 0.197 0.146  0.051 
11133 0.340 0.236  0.104  12232 0.329 0.243  0.086  13331 0.317 0.250  0.067 
11211 0.740 0.782  -0.042  12233 0.216 0.151  0.065  13332 0.205 0.158  0.047 
11212 0.627 0.690  -0.063  12311 0.616 0.481  0.135  13333 0.092 0.066  0.026 
11213 0.515 0.382  0.133  12312 0.503 0.389  0.114  21111 0.672 0.721  -0.049 
11221 0.635 0.703  -0.067  12313 0.391 0.297  0.094  21112 0.559 0.629  -0.069 
11222 0.523 0.611  -0.088  12321 0.511 0.401  0.110  21113 0.447 0.320  0.127 
11223 0.410 0.302  0.108  12322 0.399 0.309  0.090  21121 0.567 0.641  -0.073 
11231 0.531 0.406  0.124  12323 0.286 0.217  0.069  21122 0.455 0.549  -0.094 
11232 0.418 0.314  0.104  12331 0.407 0.321  0.085  21123 0.342 0.240  0.102 
11233 0.305 0.222  0.083  12332 0.294 0.229  0.065  21131 0.463 0.345  0.118 
11311 0.705 0.552  0.153  12333 0.181 0.137  0.044  21132 0.350 0.253  0.098 
11312 0.593 0.460  0.132  13111 0.596 0.437  0.159  21133 0.237 0.160  0.077 
11313 0.480 0.368  0.112  13112 0.483 0.345  0.139  21211 0.637 0.707  -0.070 
11321 0.601 0.472  0.128  13113 0.371 0.253  0.118  21212 0.525 0.615  -0.090 
11322 0.488 0.380  0.108  13121 0.491 0.357  0.134  21213 0.412 0.306  0.106 
11323 0.375 0.288  0.087  13122 0.379 0.265  0.114  21221 0.533 0.627  -0.094 
11331 0.496 0.393  0.103  13123 0.266 0.173  0.093  21222 0.420 0.535  -0.115 
11332 0.383 0.301  0.083  13131 0.387 0.277  0.110  21223 0.307 0.227  0.081 
11333 0.271 0.209  0.062  13132 0.274 0.185  0.089  21231 0.428 0.331  0.097 
12111 0.685 0.725  -0.039  13133 0.161 0.093  0.068  21232 0.315 0.239  0.077 
12112 0.573 0.633  -0.060  13211 0.561 0.423  0.138  21233 0.203 0.147  0.056 
12113 0.460 0.324  0.136  13212 0.449 0.331  0.118  21311 0.603 0.477  0.126 
12121 0.581 0.645  -0.064  13213 0.336 0.239  0.097  21312 0.490 0.385  0.105 
12122 0.468 0.553  -0.085  13221 0.457 0.343  0.113  21313 0.377 0.293  0.085 
12123 0.355 0.244  0.111  13222 0.344 0.251  0.093  21321 0.498 0.397  0.101 
12131 0.476 0.348  0.128  13223 0.231 0.159  0.072  21322 0.385 0.305  0.080 





























21331 0.394 0.317  0.076  23131 0.284 0.202  0.082  31231 0.326 0.256  0.070 
21332 0.281 0.225  0.056  23132 0.171 0.110  0.062  31232 0.213 0.164  0.049 
21333 0.168 0.133  0.035  23133 0.059 0.018  0.041  31233 0.100 0.072  0.029 
22111 0.583 0.649  -0.067  23211 0.459 0.348  0.111  31311 0.500 0.402  0.099 
22112 0.470 0.557  -0.087  23212 0.346 0.256  0.090  31312 0.388 0.310  0.078 
22113 0.357 0.249  0.109  23213 0.233 0.164  0.070  31313 0.275 0.218  0.057 
22121 0.478 0.569  -0.091  23221 0.354 0.268  0.086  31321 0.396 0.322  0.074 
22122 0.365 0.477  -0.112  23222 0.241 0.176  0.065  31322 0.283 0.230  0.053 
22123 0.253 0.169  0.084  23223 0.129 0.084  0.045  31323 0.170 0.138  0.032 
22131 0.373 0.273  0.100  23231 0.249 0.188  0.061  31331 0.291 0.242  0.049 
22132 0.261 0.181  0.080  23232 0.137 0.096  0.041  31332 0.178 0.150  0.028 
22133 0.148 0.089  0.059  23233 0.024 0.004  0.020  31333 0.066 0.058  0.008 
22211 0.548 0.636  -0.088  23311 0.424 0.334  0.090  32111 0.480 0.357  0.123 
22212 0.435 0.544  -0.108  23312 0.311 0.242  0.069  32112 0.367 0.265  0.102 
22213 0.323 0.235  0.088  23313 0.199 0.150  0.049  32113 0.255 0.173  0.081 
22221 0.443 0.556  -0.112  23321 0.319 0.254  0.065  32121 0.375 0.278  0.098 
22222 0.331 0.464  -0.133  23322 0.207 0.162  0.044  32122 0.263 0.186  0.077 
22223 0.218 0.155  0.063  23323 0.094 0.070  0.024  32123 0.150 0.094  0.057 
22231 0.339 0.260  0.079  23331 0.215 0.175  0.040  32131 0.271 0.198  0.073 
22232 0.226 0.168  0.059  23332 0.102 0.083  0.020  32132 0.158 0.106  0.052 
22233 0.113 0.076  0.038  23333 -0.011 -0.009  -0.001  32133 0.045 0.014  0.032 
22311 0.513 0.406  0.108  31111 0.569 0.429  0.141  32211 0.445 0.344  0.102 
22312 0.401 0.313  0.087  31112 0.457 0.337  0.120  32212 0.333 0.252  0.081 
22313 0.288 0.221  0.067  31113 0.344 0.245  0.099  32213 0.220 0.160  0.060 
22321 0.409 0.326  0.083  31121 0.465 0.349  0.116  32221 0.341 0.264  0.077 
22322 0.296 0.234  0.062  31122 0.352 0.257  0.095  32222 0.228 0.172  0.056 
22323 0.183 0.142  0.042  31123 0.239 0.165  0.075  32223 0.115 0.080  0.035 
22331 0.304 0.246  0.058  31131 0.360 0.269  0.091  32231 0.236 0.184  0.052 
22332 0.191 0.154  0.038  31132 0.248 0.177  0.070  32232 0.124 0.092  0.031 
22333 0.079 0.062  0.017  31133 0.135 0.085  0.050  32233 0.011 0.000  0.011 
23111 0.493 0.361  0.132  31211 0.535 0.415  0.120  32311 0.411 0.330  0.081 
23112 0.381 0.269  0.111  31212 0.422 0.323  0.099  32312 0.298 0.238  0.060 
23113 0.268 0.177  0.091  31213 0.309 0.231  0.078  32313 0.185 0.146  0.039 
23121 0.389 0.282  0.107  31221 0.430 0.335  0.095  32321 0.306 0.250  0.056 
23122 0.276 0.190  0.086  31222 0.318 0.243  0.074  32322 0.194 0.158  0.035 













        
 
32331 0.202 0.171  0.031             
32332 0.089 0.079  0.010             
32333 -0.024 -0.013  -0.010             
33111 0.391 0.286  0.105             
33112 0.278 0.194  0.084             
33113 0.165 0.102  0.063             
33121 0.286 0.206  0.080             
33122 0.173 0.114  0.059             
33123 0.061 0.022  0.039             
33131 0.181 0.126  0.055             
33132 0.069 0.034  0.034             
33133 -0.044 -0.058  0.014             
33211 0.356 0.272  0.084             
33212 0.243 0.180  0.063             
33213 0.131 0.088  0.042             
33221 0.251 0.193  0.059             
33222 0.139 0.101  0.038             
33223 0.026 0.009  0.018             
33231 0.147 0.113  0.034             
33232 0.034 0.021  0.013             
33233 -0.079 -0.071  -0.007             
33311 0.321 0.259  0.063             
33312 0.209 0.167  0.042             
33313 0.096 0.075  0.021             
33321 0.217 0.179  0.038             
33322 0.104 0.087  0.017             
33323 -0.009 -0.005  -0.004             
33331 0.112 0.099  0.013             
33332 0.000 0.007  -0.008             
33333 -0.113 -0.085  -0.028            
                
unconscious
*                 
 -0.004  0.032  -0.036            
 
                                                 
* Since unconscious is incapable of being represented by dummy variables its tariff value is the mean value from the 
sample. Health State preferences of New Zealanders  28 
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